CliffBio
small molecule

CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE

CLINDAMYCIN PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE
Active ingredientCLINDAMYCIN PHOSPHATE
StrengthEQ 300MG BASE/50ML (EQ 6MG BASE/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 2017
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.